Literature DB >> 3154321

Sympathetic activity in idiopathic dilated cardiomyopathy. Influence of captopril and hydralazine.

J Schofer1, W Bleifeld.   

Abstract

To study the interrelationship between myocardial norepinephrine content, left ventricular (LV) and right ventricular (RV) function, morphological changes, and plasma catecholamine concentrations, 20 patients with idiopathic dilated cardiomyopathy underwent endomyocardial biopsy and ventricular angiography. The strongest correlation was found between LV ejection fraction (EF) and myocardial norepinephrine content (r = 0.87; p less than 0.001). Myocardial norepinephrine content was much weaker correlated to RV EF (r = .55; p less than 0.005), and no correlation was found to morphological changes or plasma norepinephrine concentration. The hemodynamic and neurohumoral effects of hydralazine versus captopril after the first dose were compared in a crossover trial including 15 patients with idiopathic dilated cardiomyopathy. Hydralazine induced increases in heart rate and cardiac index (p less than 0.01) and decreases in mean arterial pressure and pulmonary wedge pressure (p less than 0.01 and p less than 0.005, respectively). These hemodynamic effects were associated with increased plasma norepinephrine concentrations during upright exercise (p less than 0.05) and increased plasma renin activity (p less than 0.01). After captopril, norepinephrine plasma concentrations showed a tendency to lower levels during upright exercise, although mean arterial pressure decreased significantly (p less than 0.01). These data suggest that, in patients with idiopathic dilated cardiomyopathy, myocardial norepinephrine depletion strongly reflects left ventricular dysfunction. The different patterns of neurohumoral response to hydralazine versus captopril may be important for their long-term effect and for the prognosis of patients with idiopathic dilated cardiomyopathy. It remains to be established whether the myocardial catecholamine content is differently influenced by either drug, and whether this effect is related to the drug response after long-term treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3154321     DOI: 10.1007/bf02125471

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  21 in total

1.  Use of biplane cinefluorography for measurement of ventricular volume.

Authors:  C B CHAPMAN; O BAKER; J REYNOLDS; F J BONTE
Journal:  Circulation       Date:  1958-12       Impact factor: 29.690

2.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine.

Authors:  J D Peuler; G A Johnson
Journal:  Life Sci       Date:  1977-09-01       Impact factor: 5.037

Review 3.  Vasodilator drugs in the treatment of hypertension.

Authors:  J Koch-Weser
Journal:  Arch Intern Med       Date:  1974-06

Review 4.  Cardiovascular effects of angiotensin mediated by the central nervous system.

Authors:  C M Ferrario; P L Gildenberg; J W McCubbin
Journal:  Circ Res       Date:  1972-03       Impact factor: 17.367

5.  Distrubution of norepinephrine in the failing bovine heart. Correlation of chemical analysis and fluorescene microscopy.

Authors:  J H Vogel; D Jacobowitz; C A Chidsey
Journal:  Circ Res       Date:  1969-01       Impact factor: 17.367

6.  Sympathetic activity and neurotransmitter depletion in congestive heart failure.

Authors:  C A Chidsey; E Braunwald
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

7.  Uptake of catecholamines by human cardiac muscle in vitro.

Authors:  M C Petch; W G Nayler
Journal:  Br Heart J       Date:  1979-03

8.  Adrenal medullary stimulation induced by angiotensin I, angiotensin II, and analogues.

Authors:  M J Peach
Journal:  Circ Res       Date:  1971-05       Impact factor: 17.367

9.  Angiotensin-converting enzyme inhibitor resets baroreceptor reflexes in conscious dogs.

Authors:  R Hatton; D Clough; K Faulkner; J Conway
Journal:  Hypertension       Date:  1981 Nov-Dec       Impact factor: 10.190

10.  Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure.

Authors:  G S Francis; S R Goldsmith; J N Cohn
Journal:  Am Heart J       Date:  1982-10       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.